Skip to main content

Dentsply Sirona Value Stock - Dividend - Research Selection

Dentsply sirona

ISIN: US24906P1093 , WKN: A2AF0E

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Solventum Partners With SprintRay for Same-Day Dental Restorations

2025-03-31
SOLV partners with SprintRay to introduce an innovative solution for same-day dental restorations, enhancing efficiency, precision and patient care in digital dentistry.

3 Stocks Under $50 Skating on Thin Ice

2025-03-28
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.

Dividend Champion, Contender, And Challenger Highlights: Week Of March 23

2025-03-22
Stay updated with weekly dividend activity for Champions, Contenders, and Challengers. Learn about changes, ex-dividend dates, and upcoming pay dates.

Lazard Equity Franchise Portfolio Q4 2024 Commentary

2025-03-20
In Q4 2024, the Lazard Equity Franchise Portfolio fell in absolute terms and underperformed its benchmark, the MSCI World Index. Click here to read the full commentary.

Dentsply Sirona enters $435 mln bridge loan agreement

2025-03-19
DENTSPLY SIRONA Inc: * DENTSPLY SIRONA INC - ENTERS $435 MILLION BRIDGE LOANAGREEMENT- SEC FILING * DENTSPLY SIRONA INC - FUNDS TO REPAY COMMERCIAL PAPERBORROWINGSAND...

Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader

2025-03-17
CHARLOTTE, N.C., March 17, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (XRAY) today announced that David Ferguson has been appointed Senior Vice President, Global Business Unit Leader, effective March 14, 2025. In this role he will lead the global business unit teams managing the dental product portfolio, serve as a member of the Executive Management Team and report directly to Chief Executive Officer, Simon Campion. David Ferguson joins Dentsply Sirona wit

Dentsply Sirona : and Rapid Shape Announce Partnership

2025-03-14
Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, and Rapid Shape, a leading innovator in German-engineered dental 3D printing technology...

Needham cuts Dentsply Sirona and ZimVie to ‘hold’ on weak dental market outlook

2025-03-13
Investing.com -- Needham downgraded Dentsply Sirona and ZimVie to Hold from Buy, citing a lack of near-term catalysts and continued weakness in the dental market.

Here’s What Weakened DENTSPLY SIRONA (XRAY) Shares

2025-03-13
Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The Russell Midcap® Value Index ended Q4 somewhat lower, down -1.75%, after posting robust gains in Q3. The index provided a 13.07% return for the year. Following the […]

Utah fluoride ban could be marginal tailwind to dental demand, says BofA

2025-03-12
BofA notes that Utah’s House and Senate passed a bill that would ban the fluoridation of water and that news sources indicate that Utah’s Governor intends to sign the bill into law. Banning of water fluoridation in Utah could be “a marginal tailwind to dental demand in the state over a long period of time,” according to the analyst, who is watching to see if other states follow suit while noting that North Dakota, Tennessee, and Montana had or have similar bills introduced in relation to banning